|
ESC CONGRESS 2019
31 August - 04 September 2019, Paris - France
Session Details
|
Novel pharmacological targets in vascular disease
|
Sat 31 Aug
|
09:00 - 10:30
|
Basic Science
|
Advances in Science, Abstract-based Programme
|
Pristina - Village 3
|
Chairpersons: Lina BADIMON (Barcelona, Spain), Iris BAUMGARTNER (Bern, Switzerland)
|
Other resources
List of Presentations
Loading...
09:00 | 53 | State of the Art - Metabolic aspects of vascular disease | Massimo FEDERICI (Rome, Italy) |
|
09:18 | 54 | Role of the gut microbiome for the cholesterol lowering effect of atorvastatin | Friederike Luise ZIMMERMANN (, Germany) |
|
09:36 | 55 | Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds- | Ryo KUROSAWA (Sendai, Japan) |
|
09:54 | 56 | The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension | Subodh VERMA (Toronto, Canada) |
|
10:12 | 57 | Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury | Rhian TOUYZ (Glasgow, United Kingdom of Great Britain & Northern Ireland) |
|
|
|
|